N-myristoylethanolamine,
142-58-5,
N-(2-HYDROXYETHYL)TETRADECANAMIDE,
N-(2-Hydroxyethyl)myristamide,
Myristic monoethanolamide,
myristoyl ethanolamide,
Tetradecanamide, N-(2-hydroxyethyl)-,
N-myristoylethanolamine,
Myristamide MEA,
Comperlan MM,
Myristoyl-EA,
Loramine MY 228,
UNII-6CYG57WXZ0,
N-(Tetradecanoyl)-ethanolamine,
Myristoyl-ethanolamine,
tetradecanoyl ethanolamide,
Myristoyl monoethanolamide,
6CYG57WXZ0,
Monoethanolamine myristic acid condensate,
Schercomid MME,
Myristyl monoethanolamide,
HSDB 5640,
EINECS 205-546-5,
AC1Q5PMK,
N-(myristoyl)ethanolamine,
N-tetradecanoylethanolamine,
AC1L1RW4,
N-(tetradecanoyl)ethanolamine,
SCHEMBL308261,
GTPL5221,
DTXSID0042452,
CHEBI:85262,
CTK4C3192,
NAE14:0,
KS-000002BJ,
LMFA08040042,
MFCD02670245,
Tetradecanamide,N-(2-hydroxyethyl)-,
ZINC59725634,
AKOS002676442,
AM 3165,
MCULE-9095389474,
AN-23234,
TETRADECANOIC ACID (2-HYDROXY-ETHYL)-AMIDE,
UNII-3VVG2UI23S component JHIXEZNTXMFXEK-UHFFFAOYSA-N,
UNII-C80684146D component JHIXEZNTXMFXEK-UHFFFAOYSA-N,
C16H33NO2,
CID8890,
N- (2- hydroxyethyl)myristamide,
AR-1J8026,
C16-H33-N-O2,
1442-83-7,
MEA,